StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Puma Biotechnology's EV/EBITDA was 8.0× on Nov 11, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 2.6× to 27.6×, with a median of 6.1×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.0×+2.5
2025Dec 31, 20255.5×+2.4
2024Dec 31, 20243.1×−3.5
2023Dec 29, 20236.6×−1.3
2022Dec 30, 20227.9×−11.6
2021Jul 30, 202119.5×–

More Puma Biotechnology figures

See a number that looks wrong?